| Title: | Cardiovascular Technology |
| Price: | $495.00 |
| Publication Date: | Dec 03, 2007 |
| Source: | IncreMental Advantage |
| Brief Excerpt: | ...In this special report, Incremental Advantage profiles several companies focused on developing new therapies in the field of cardiovascular research. Products in development range from devices that assist in regulating the heart rhythm, to replacing cells lost to heart disease. Some companies are developing devices that improve on the current treatments with new technologies, while others have unique devices which, at the current time, have no known marketed counterparts. There are some that are looking to improve on current therapies with devices that are smaller, more efficient, and less invasive. While most current treatments for heart attacks try to slow the progression of the patient s heart failure after a heart attack, some of the companies we profiled are using cellular therapy to repair damage to the heart after heart attacks. These therapies seek to reverse the damage to the heart and restore structure and functionality. Most media reports on stem cell research focus... |
| Word Count: | 37618 |
| Length: | 53 Pages |
| Document ID: | Cardio123 |
| Industry: | Biotechnology |
| Country: | United States |
| Format: | 
Adobe Acrobat
|
| Free Sample: |
Click
Here
to Download
|
Looking For Something Else?
